These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37204173)

  • 1. Reply: Concurrent large spontaneous portosystemic shunt embolization for the prevention of overt hepatic encephalopathy after TIPS: A randomized controlled trial.
    Lv Y; Han G
    Hepatology; 2023 Sep; 78(3):E58. PubMed ID: 37204173
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter to the Editor: Concurrent large spontaneous portosystemic shunt embolization for the prevention of overt hepatic encephalopathy after TIPS: A randomized controlled trial.
    Yin HJ; Wan YM
    Hepatology; 2023 Sep; 78(3):E56-E57. PubMed ID: 37204164
    [No Abstract]   [Full Text] [Related]  

  • 3. Concurrent large spontaneous portosystemic shunt embolization for the prevention of overt hepatic encephalopathy after TIPS: A randomized controlled trial.
    Lv Y; Chen H; Luo B; Bai W; Li K; Wang Z; Xia D; Guo W; Wang Q; Li X; Yuan J; Cai H; Xia J; Yin Z; Fan D; Han G
    Hepatology; 2022 Sep; 76(3):676-688. PubMed ID: 35266571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent spontaneous portosystemic shunt embolization for the prevention of overt hepatic encephalopathy after TIPS: A systematic review and meta-analysis.
    Yang M; Qiu Y; Wang W
    Dig Liver Dis; 2024 Jun; 56(6):978-985. PubMed ID: 37926635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic embolization of large spontaneous portosystemic shunts with transjugular intrahepatic portosystemic shunt (TIPS): A panacea for post-TIPS hepatic encephalopathy?
    Tripathi D; Bureau C
    Hepatology; 2022 Sep; 76(3):551-553. PubMed ID: 35429167
    [No Abstract]   [Full Text] [Related]  

  • 6. Eight millimetre covered TIPS does not compromise shunt function but reduces hepatic encephalopathy in preventing variceal rebleeding.
    Wang Q; Lv Y; Bai M; Wang Z; Liu H; He C; Niu J; Guo W; Luo B; Yin Z; Bai W; Chen H; Wang E; Xia D; Li X; Yuan J; Han N; Cai H; Li T; Xie H; Xia J; Wang J; Zhang H; Wu K; Fan D; Han G
    J Hepatol; 2017 Sep; 67(3):508-516. PubMed ID: 28506905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of the curative effect of transjugular intrahepatic portosystemic shunt with expanded polytetrafluoroethylene-covered stent and drug combined with gastroscopy as the secondary prevention of esophageal -gastric variceal bleeding in portal hypertension].
    Lin ZP; Chen SL; Wang JY; Liu F; Tan Q; Peng QF; Zhao JB
    Zhonghua Gan Zang Bing Za Zhi; 2020 Aug; 28(8):672-678. PubMed ID: 32911906
    [No Abstract]   [Full Text] [Related]  

  • 8. Association between non-variceal spontaneous portosystemic shunt and outcomes after TIPS in cirrhosis.
    He C; Lv Y; Wang Z; Guo W; Tie J; Li K; Niu J; Zuo L; Yu T; Yuan X; Chen H; Wang Q; Liu H; Bai W; Wang E; Xia D; Luo B; Li X; Yuan J; Han N; Zhu Y; Wang J; Yin Z; Fan D; Han G
    Dig Liver Dis; 2018 Dec; 50(12):1315-1323. PubMed ID: 29960900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of transjugular intrahepatic portosystemic shunt (TIPS) alone and combined with embolisation for the management of cardiofundal varices: a retrospective study.
    Yu J; Wang X; Jiang M; Ma H; Zhou Z; Yang L; Li X
    Eur Radiol; 2019 Feb; 29(2):699-706. PubMed ID: 30039223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Embolization of spontaneous splenorenal shunt for after-TIPS hepatic encephalopathy in a patient with cirrhosis and variceal bleeding.
    Wu W; He C; Han G
    Hepatology; 2015 May; 61(5):1761-2. PubMed ID: 25212730
    [No Abstract]   [Full Text] [Related]  

  • 11. The influence of shunting left/right portal vein branch on post-TIPS hepatic encephalopathy: a study protocol for multicenter randomized blinded controlled trial.
    Ma J; Luo J; Zhang W; Zhou Y; Zhang Z; Yang M; Zhuang Z; Ma L; Yu J; Zhou X; Yan Z
    Trials; 2023 May; 24(1):312. PubMed ID: 37149647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The presence of spontaneous portosystemic shunts increases the risk of complications after transjugular intrahepatic portosystemic shunt (TIPS) placement.
    Borentain P; Soussan J; Resseguier N; Botta-Fridlund D; Dufour JC; Gérolami R; Vidal V
    Diagn Interv Imaging; 2016 Jun; 97(6):643-50. PubMed ID: 26947721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative outcome of transjugular intrahepatic portosystemic shunt with or without variceal obliteration: a systematic review and meta-analysis.
    Giri S; Patel RK; Varghese J; Agarwal D; Tripathy T
    Abdom Radiol (NY); 2023 Apr; 48(4):1429-1437. PubMed ID: 36821005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refractory hepatic encephalopathy due to concomitant transjugular intrahepatic portosystemic shunt and spontaneous mesocaval shunt controlled by embolization of the competitive portosystemic shunt.
    Cura M
    Clin Imaging; 2009; 33(3):231-3. PubMed ID: 19411031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Use of Rifaximin in the Prevention of Overt Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt : A Randomized Controlled Trial.
    Bureau C; Thabut D; Jezequel C; Archambeaud I; D'Alteroche L; Dharancy S; Borentain P; Oberti F; Plessier A; De Ledinghen V; Ganne-Carrié N; Carbonell N; Rousseau V; Sommet A; Péron JM; Vinel JP
    Ann Intern Med; 2021 May; 174(5):633-640. PubMed ID: 33524293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant Transjugular Variceal Occlusion at Creation of a Transjugular Intrahepatic Portosystemic Shunt (TIPS): Efficacy and Risks of Bucrylate Embolization.
    Schultheiß M; Giesler M; Maruschke L; Schmidt A; Sturm L; Thimme R; Rössle M; Bettinger D
    Cardiovasc Intervent Radiol; 2019 May; 42(5):729-736. PubMed ID: 30788517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in patients with cirrhosis: a randomised trial.
    Pomier-Layrargues G; Villeneuve JP; Deschênes M; Bui B; Perreault P; Fenyves D; Willems B; Marleau D; Bilodeau M; Lafortune M; Dufresne MP
    Gut; 2001 Mar; 48(3):390-6. PubMed ID: 11171831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of transjugular intrahepatic portosystemic shunt for treatment of variceal bleeding in patients with cirrhosis with or without spontaneous portosystemic shunt.
    Leng X; Zhang F; Zhang M; Guo H; Yin X; Xiao J; Wang Y; Zou X; Zhuge Y
    Eur J Gastroenterol Hepatol; 2019 Jul; 31(7):853-858. PubMed ID: 30633039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Efficacy of Transjugular Intrahepatic Portosystemic Shunt Created with Expanded Polytetrafluoroethylene-Covered Stent-Grafts: 8-mm Versus 10-mm.
    Luo X; Wang X; Zhu Y; Xi X; Zhao Y; Yang J; Li X; Yang L
    Cardiovasc Intervent Radiol; 2019 May; 42(5):737-743. PubMed ID: 30643936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of hepatic encephalopathy by administration of rifaximin and lactulose in patients with liver cirrhosis undergoing placement of a transjugular intrahepatic portosystemic shunt (TIPS): a multicentre randomised, double blind, placebo controlled trial (PEARL trial).
    de Wit K; Schaapman JJ; Nevens F; Verbeek J; Coenen S; Cuperus FJC; Kramer M; Tjwa ETTL; Mostafavi N; Dijkgraaf MGW; van Delden OM; Beuers UHW; Coenraad MJ; Takkenberg RB
    BMJ Open Gastroenterol; 2020 Dec; 7(1):. PubMed ID: 33372103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.